Afya (NASDAQ:AFYA) Coverage Initiated by Analysts at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Afya (NASDAQ:AFYA) in a report released on Tuesday morning, Marketbeat.com reports. The brokerage issued a sell rating and a $16.00 target price on the stock.

Separately, UBS Group started coverage on Afya in a report on Friday, August 30th. They set a “neutral” rating and a $19.50 target price on the stock.

Afya Stock Performance

Shares of Afya stock opened at $15.96 on Tuesday. Afya has a 52 week low of $15.28 and a 52 week high of $22.48. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of 12.87, a PEG ratio of 0.34 and a beta of 0.89. The firm has a fifty day moving average of $16.80 and a two-hundred day moving average of $17.11.

Institutional Trading of Afya

Hedge funds have recently added to or reduced their stakes in the business. Lifestyle Asset Management Inc. raised its position in shares of Afya by 13.3% during the third quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company’s stock worth $286,000 after purchasing an additional 1,969 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in Afya during the 3rd quarter worth approximately $34,000. Quarry LP bought a new stake in shares of Afya during the third quarter worth $75,000. Quantbot Technologies LP increased its position in shares of Afya by 73.8% during the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after acquiring an additional 5,636 shares in the last quarter. Finally, Centiva Capital LP acquired a new stake in shares of Afya during the third quarter worth $213,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.